单聚糖可溶性微针用于无痛局部麻醉:制造,表征和体外神经成像
João M S P Leite1, Ana C Q Silva1, Ana Jesus2,3
1CICECO - Aveiro Institute of Materials, Department of Chemistry, University of Aveiro, Aveiro 3810-193, Portugal.
ACS biomaterials science & engineering
|August 1, 2025
概括
这项研究开发了可溶性Pullulan微针,用于快速,微创的利多卡因输送. 微针有效地通过皮肤输送麻醉剂,与传统方法相比,显示出高安全性和效率.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 皮肤病学 皮肤病学
背景情况:
- 微针 (MNs) 提供了一种对传统药物管理方法的最小侵入性替代方案.
- 基于多糖的MNs提供了一个有前途的生物降解平台,用于通过皮肤递送药物.
- 利多卡因是一种广泛使用的局部麻醉剂,需要有效和快速的输送方法.
研究的目的:
- 开发和表征单组件普鲁兰微针用于通过皮肤输送利多卡因.
- 评估Pullulan MNs的机械强度,皮肤透和溶解特性.
- 评估基于Pullulan MN的利多卡因输送系统的安全性和有效性.
主要方法:
- 微型模具被用来制造Pullulan微针.
- 机械测试评估了针的强度.
- 使用切除的人体皮肤和皮肤模型来评估角层透和溶解.
- 在HaCaT,3T3和RAW 264.7细胞系上使用resazurin代谢试验测试了细胞相容性.
- 时间延迟光显微镜比较利多卡因释放的疗效.
主要成果:
- 普鲁兰微针显示出高的机械强度 (高达1.5N/针).
- 在10分钟内成功透切除的人类腹部皮肤,并在皮肤模型中溶解.
- 10分钟后,在贴片中的利多卡因保留率为26% (糖凝) 和32% (猪皮).
- 超过80%的细胞活力证实了多个细胞系的细胞相容性.
- 经MN递送的利多卡因在感觉神经元上表现出与纯溶液相当的活性.
结论:
- 可溶性Pullulan微针是一种安全有效的通过皮肤输送利多卡因的系统.
- 这种系统提供了快速起作用 (<10分钟) 和高效的药物释放.
- 普鲁兰MNs代表了传统局部麻醉剂施用方法的有希望的替代方案.
相关概念视频
Local Anesthetics: Differential Sensitivity of Nerve Fibers
935
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
935
Local Anesthetics: Chemistry and Structure-Activity Relationship
5.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
5.4K


